Predicting Survival with Brain Metastases in the Stereotactic Radiosurgery Era: are Existing Prognostic Scores Still Relevant? Or Can we do Better?

M.W. Fittall,M. Brewer,J. de Boisanger,L. Kviat,A. Babiker,H. Taylor,F. Saran,J. Konadu,F. Solda,A. Creak,L.C. Welsh,N. Rosenfelder
DOI: https://doi.org/10.1016/j.clon.2024.01.037
IF: 4.925
2024-02-01
Clinical Oncology
Abstract:Predicting survival is essential to tailoring treatment for patients diagnosed with brain metastases. We have evaluated the performance of widely used, validated prognostic scoring systems (Graded Prognostic Assessment and diagnosis-specific Graded Prognostic Assessment) in over 1000 'real-world' patients treated with stereotactic radiosurgery to the brain, selected according to National Health Service commissioning criteria. Survival outcomes from our dataset were consistent with those predicted by the prognostic systems, but with certain cancer subtypes showing a significantly better survival than predicted. Although performance status remains the simplest tool for prediction, total brain tumour volume emerges as an independent prognostic factor, and a new, improved, prognostic scoring system incorporating this has been developed.
oncology
What problem does this paper attempt to address?